HRMY:NASDAQ, Harmony Biosciences Holdings, Inc.

HRMY stock overview

Harmony Biosciences Holdings, Inc. (HRMY:NASDAQ) closed at $36.13 on October 23, 2026, up 0.28% on the day. The stock trades 16.9% below its 52-week high of $43.49 and 39.5% above its 52-week low of $25.90. Over the past year, it gained 19.4%. Harmony Biosciences Holdings, Inc. is part of the Health Care sector.

Key figures

Price: $36.13
Day change: +0.28%
Volume: 2,313,563
Average volume: 914,076
Market cap: 2B+
52-week range: $25.90 – $43.49
50-day average: $39.86
200-day average: $34.68

Price action over the past year

In 252 trading sessions since October 23, 2025, HRMY closed higher on 129 days (51%). Its best day was October 23, 2025 (+12.68%) and its worst was February 20, 2026 (-15.21%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

Oct 23, 2026: Trading sideways between $36.03 and $41.26 over 30 days (Sideways scanner)
Oct 22, 2026: News catalyst: Investor Update (News Catalysts scanner)

HRMY news

Oct 22, 2026: HRMY or ARGX: Which Is the Better Value Stock Right Now?
Oct 22, 2026: Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?
Oct 22, 2026: Revisiting Former Stock Picks Marriott, Logitech, Harmony Biosciences
Oct 20, 2026: Harmony Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026
Oct 16, 2026: HRMY Stock Gains 27.6% in Six Months: Is There More Room for Growth?
Oct 12, 2026: Why Harmony Biosciences Stock Got Mashed on Monday
Oct 12, 2026: Harmony Bio CEO Plans His Exit, And Shares Take An Unharmonious Hit
Oct 12, 2026: Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth

About Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs.

Similar stocks

Find more stocks like HRMY with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.